Overview

Mild To Moderate Erectile Dysfunction Study

Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
0
Participant gender:
Male
Summary
Safety/Efficacy of 100-mg Viagra at 8 hours post dose in men with mild to moderate erectile dysfunction
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Sildenafil Citrate
Criteria
Inclusion Criteria:

- Men 18-70 years of age

- Documented clinical diagnosis of erectile dysfunction of at least 3 months duration.

Exclusion Criteria:

- Subjects with penile implants

- Subjects with a known history of retinitis pigmentosa.

- Subjects, due to the requirement of 100 mg dosage, who are receiving concomitant
treatment with the potent CYP3A4 inhibitor ritonavir.